Recordati Industria Chimica e Farmaceutica S.p.A.

Milan Stock Exchange:REC.MI

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

Location

Italy

Market Cap

USD 12.84 B

Share Price

USD 62.16

Avg Daily Volume

398,333

Change (1 day)

1.46%

Change (1 year)

17.96%

Change (YTD)

18.04%

Recordati Industria Chimica e Farmaceutica S.p.A. Dividend Yield on June 20, 2025: 2.05%

Recordati Industria Chimica e Farmaceutica S.p.A. Dividend Yield is 2.05% on June 20, 2025, a -17.39% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Recordati Industria Chimica e Farmaceutica S.p.A. 52-week low Dividend Yield is 2.56% on June 20, 2025, which is 24.91% above the current Dividend Yield.
Recordati Industria Chimica e Farmaceutica S.p.A. 52-week low Dividend Yield is 1.99% on June 20, 2025, which is -2.93% below the current Dividend Yield.
Recordati Industria Chimica e Farmaceutica S.p.A. average Dividend Yield for the last 52 weeks is 2.29%.

Daily

From:

To:

Zoom:

Key data

Date	Dividend Yield	Market Capitalization	Share Price	Share Price

Milan Stock Exchange: REC.MI

Recordati Industria Chimica e Farmaceutica S.p.A.

CEO	Dr. Robert Koremans M.D.
IPO Date	March 28, 1995
Location	Italy
Headquarters	1, Via Matteo Civitali
Employees	4,580
Sector	🏥 Health Care
Industries Pharmaceuticals

Description

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.